II constricts descending vasa recta (DVR) through Ca 2ϩ signaling in pericytes. We examined the role of PKC DVR pericytes isolated from the rat renal outer medulla. The PKC blocker staurosporine (10 M) eliminated ANG II (10 nM)-induced vasoconstriction, inhibited pericyte cytoplasmic Ca 2ϩ concentration ([Ca 2ϩ ]cyt) elevation, and blocked Mn 2ϩ influx into the cytoplasm. Activation of PKC by either 1,2-dioctanoyl-sn-glycerol (10 M) or phorbol 12,13-dibutyrate (PDBu; 1 M) induced both vasoconstriction and pericyte [Ca 2ϩ ]cyt elevation. Diltiazem (10 M) blocked the ability of PDBu to increase pericyte [Ca 2ϩ ]cyt and enhance Mn 2ϩ influx. Both ANG II-and PDBu-induced PKC stimulated DVR generation of reactive oxygen species (ROS), measured by oxidation of dihydroethidium (DHE). The effect of ANG II was only significant when ANG II AT2 receptors were blocked with PD-123319 (10 nM). PDBu augmentation of DHE oxidation was blocked by either TEMPOL (1 mM) or diphenylene iodonium (10 M). We conclude that ANG II and PKC activation increases DVR pericyte [Ca 2ϩ ]cyt, divalent ion conductance into the cytoplasm, and ROS generation. medulla; kidney; microcirculation; calcium; oxidative stress DESCENDING VASA RECTA (DVR) supply the majority of blood flow to the renal medulla and are the site of regulation of blood flow distribution between the outer and inner medulla. DVR smooth muscle/pericytes envelop the vessel and contract to induce vasoconstriction. On the basis of these considerations, we infer that the DVR pericytes are an important regulator of regional perfusion of the kidney and potentially play roles in medullary oxygenation, salt excretion, and the urinary concentrating mechanism (30 (10, 18, 19, 30, 37, 47) . To expand our understanding of the pathways that lead to pericyte contraction, we tested the hypothesis that PKC activation is involved in ANG II constriction of DVR and ROS generation in DVR pericytes. Our results confirm that blockade of PKC prevents ANG II [Ca 2ϩ ] cyt signaling and DVR contraction. Conversely, PKC activation constricts DVR and elevates [Ca 2ϩ ] cyt . Both ANG II AT 1 receptor stimulation and PKC activation induce ROS generation. ANG II AT 2 receptor activation moderates ROS production.
concentration ([Ca 2ϩ ]cyt) elevation, and blocked Mn 2ϩ influx into the cytoplasm. Activation of PKC by either 1,2-dioctanoyl-sn-glycerol (10 M) or phorbol 12,13-dibutyrate (PDBu; 1 M) induced both vasoconstriction and pericyte [Ca 2ϩ ]cyt elevation. Diltiazem (10 M) blocked the ability of PDBu to increase pericyte [Ca 2ϩ ]cyt and enhance Mn 2ϩ influx. Both ANG II-and PDBu-induced PKC stimulated DVR generation of reactive oxygen species (ROS), measured by oxidation of dihydroethidium (DHE). The effect of ANG II was only significant when ANG II AT2 receptors were blocked with PD-123319 (10 nM). PDBu augmentation of DHE oxidation was blocked by either TEMPOL (1 mM) or diphenylene iodonium (10 M). We conclude that ANG II and PKC activation increases DVR pericyte [Ca 2ϩ ]cyt, divalent ion conductance into the cytoplasm, and ROS generation. medulla; kidney; microcirculation; calcium; oxidative stress DESCENDING VASA RECTA (DVR) supply the majority of blood flow to the renal medulla and are the site of regulation of blood flow distribution between the outer and inner medulla. DVR smooth muscle/pericytes envelop the vessel and contract to induce vasoconstriction. On the basis of these considerations, we infer that the DVR pericytes are an important regulator of regional perfusion of the kidney and potentially play roles in medullary oxygenation, salt excretion, and the urinary concentrating mechanism (30) . Motivated by this, we investigated the signaling pathways and channel architecture of the DVR pericyte. ANG II depolarizes pericytes by activating a Ca 2ϩ -dependent Cl Ϫ conductance (28, 52) leading to voltage-gated Ca 2ϩ entry into the cytoplasm and DVR contraction (26, 35, 52 ] cyt and dilates preconstricted DVR (26, 52) . In many smooth muscle cells, signaling cascades activated by contractile agonists include effects mediated by PKC. These include activation of voltage-gated Ca 2ϩ channels and Ca 2ϩ -dependent Cl Ϫ channels (17, 25) . In addition, through phosphorylation of NADPH oxidase, PKC favors generation of superoxide and other reactive oxygen species (ROS). ROS may serve to sensitize the contractile machinery to [Ca 2ϩ ] cyt and modulate vasodilation by reducing bioavailable nitric oxide (NO) (10, 18, 19, 30, 37, 47) . To expand our understanding of the pathways that lead to pericyte contraction, we tested the hypothesis that PKC activation is involved in ANG II constriction of DVR and ROS generation in DVR pericytes. Our results confirm that blockade of PKC prevents ANG II [Ca 2ϩ ] cyt signaling and DVR contraction. Conversely, PKC activation constricts DVR and elevates [Ca 2ϩ ] cyt . Both ANG II AT 1 receptor stimulation and PKC activation induce ROS generation. ANG II AT 2 receptor activation moderates ROS production.
MATERIALS AND METHODS

Isolation of DVR.
The investigations involving animal use described herein were performed according to protocols approved by the Institutional Animal Care and Use Committee of the University of Maryland. Kidneys were harvested from Sprague-Dawley rats (70 -150 g; Harlan Sprague Dawley, Indianapolis, IN) that were anesthetized by an intraperitoneal injection of ketamine (50 mg/kg) and xylazine (5 mg/kg). Tissue slices were placed in buffer and maintained at 4°C. Individual DVR was dissected from vascular bundles of the renal outer medulla and transferred to the stage of an inverted microscope where fluorescence microscopy or microperfusion studies were performed as previously described (27, 29) . The solution used for dissection, microperfusion, and measurement of vasoactivity contained (in mM) 140 NaCl, 10 Na acetate, 5 KCl, 1.2 MgSO 4, 1.2 Na2HPO4, 1 CaCl2, 5 HEPES, 5 L-alanine, and 5 D-glucose and 0.5 g/dl bovine albumin. The pH was adjusted to 7.55 at room temperature using NaOH to yield a pH of about 7.4 at 37°C.
Measurement of DVR diameter. Vasoactivity was monitored in DVR perfused in vitro as previously described (27, 29) . Vessel images were recorded on videotape (Panasonic WV-BL90), and diameters were analyzed during playback. DVR luminal diameter was observed with a ϫ40 objective to yield the final magnification of ϫ1,300. Isolation of pericytes from DVR wall. Small wedges of renal medulla were separated from kidney slices by dissection, transferred to CaCl 2-free physiological saline solution (PSS) containing collagenase 1A (0.45 mg/ml; Sigma), protease XIV (0.4 mg/ml; Sigma), and albumin (1.0 mg/ml) (28, 35) , incubated at 37°C for 22 min, and then transferred back to PSS containing CaCl 2 (1 mM). Digested tissue was subsequently held at 4°C in a petri dish. At intervals, vessels were isolated from the digested renal tissue by microdissection and transferred to a perfusion chamber. In the chamber, DVR were captured and aspirated into a microperfusion-style collection pipette whose opening was 5-10 m. During aspiration, pericytes were stripped from the abluminal surface of the vessel. As previously described, the DVR can be completely drawn into the pipette, leaving a preparation of isolated pericytes that adhere to the tip (34, 35, 52) .
Immunolabeling of DVR pericytes and endothelia. To verify the identity of DVR pericytes and endothelium, vessels were immunolabeled with monoclonal antibody against smooth muscle actin (1:400 dilution; Sigma) and polyclonal antibody against as Na ϩ /H ϩ exchanger regulating factor-2 (NHERF-2) (1:100 dilution). The NHERF-2 antibody has been described (41) . DVR were fixed in 0.1 M cacodylate buffer with 3% paraformaldehyde for 5 min, washed twice with PSS, and then blocked for 30 min with PBS containing 5% bovine serum albumin and 0.1% triton, all at room temperature. Immunolabeling was performed by incubating sequentially with primary antibody and secondary antibody, 1 h each, at room temperature. Secondary antibodies were conjugated to Alexa Fluor 488 (goat anti-rabbit for NHERF-2) or Alexa Fluor 568 (Molecular Probes, Eugene, OR; goat anti-mouse for smooth muscle actin). Vessels were mounted in Antifade (Molecular Probes) and imaged with a Zeiss LSM410 laser scanning confocal microscope.
Measurement of [Ca 2ϩ ]cyt. Pericytes were loaded with fura-2 by incubating them with the AM (10 M, Molecular Probes) for 20 min at 37°C in the presence of probenecid (1 mM) (35) . A photoncounting photomultiplier (PMT) assembly was employed to measure the fluorescent emission of fura-2 at 510 nm. Excitation was provided by a 75-W xenon arc lamp using a 350/380-nm wavelength combination isolated with a computer-controlled monochrometer (PTI; Lawrenceville, NJ). Fluorescent emission was isolated with a 510WB40 bandpass filter (Omega Optical; Brattleboro, VT) and collected with a Nikon CF fluor ϫ40 oil immersion objective (1.3 numerical aperture). The background-subtracted ratio of fluorescent emission (R350/380) was converted to the [Ca 2ϩ ]cyt assuming a dissociation constant of 224 nM for fura-2 at 37°C. R max and Rmin were measured by exposing vessels to buffer containing 5 mM CaCl 2 or 0 CaCl 2, 0.5 mM EGTA, respectively, and 10 M ionomycin (29, 34, 52) .
Measurement of Mn 2ϩ influx by quench of fura-2. Mn 2ϩ quench of fura-2 fluorescence was used to measure the effects of PKC activation and inhibition on conductance of the pericyte membrane to divalent cations (29, 34) . Pericytes were loaded with fura-2 as described in Measurement of [Ca 2ϩ ]cyt. To avoid changes in fura-2 fluorescence due to variations of pericyte [Ca 2ϩ ]cyt, fura-2 was excited at its isosbestic (Ca 2ϩ -insensitive) wavelength, 360 nm. Fluorescent emission of fura-2 was measured at 510 nm before and after the introduction of MnCl2 (0.5 mM) into the bath. The rate of Mn 2ϩ entry into pericytes was inferred from the rate at which fura-2 fluorescence was quenched by Mn 2ϩ in the cytoplasm.
Measurement of ROS generation by oxidation of dihydroethidium.
To measure generation of ROS, we included dihydroethidium (DHE) (10 M) in the bath. Within cells, this probe is oxidized by superoxide (O 2 Ϫ ⅐ ) to fluorescent products that are trapped by intercalation into DNA. This probe is generally thought to be specific for O 2 Ϫ ⅐ but ethidium (ETH) may not be its sole product (53) . Single DVR were dissected, immobilized on pipettes in flowing bath, and excited at 535 nm. ETH emissions were monitored at 635 nm using a PMT assembly. To assess the distribution of ETH in the DVR wall, confocal images of ETH-loaded vessels were obtained with a Zeiss LSM410 laser scanning confocal microscope.
Reagents. ANG II, PD-123319, diphenylene iodonium (DPI), 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (TEMPOL), probenecid, diltiazem, ionomycin, collagenase 1A, protease XIV, staurosporine (STP), phorbol 12,13-dibutyrate (PDBu), and 1,2-dioctanoyl-sn-glycerol (DiOG) were from Sigma (St. Louis, MO). ANG II, probenecid, diltiazem, DPI, and TEMPOL were stored in water at Ϫ20°C and diluted 1:100 or 1:1,000 on the day of the experiment. Fura-2, DHE (Molecular Probes), STP, PDBu, and DiOG were stored frozen in DMSO, thawed, and diluted for daily use. The digestion solution used to free pericytes from the endothelium was stored frozen in 2 ml aliquots and thawed once daily as needed. Excess reagents were discarded at the end of each day.
Statistics and analysis. Data in the text and figures are shown as means Ϯ SE. Fluorescence acquisition rates were most often so rapid that graphing all error bars obscures data points. Consequently, in the figures that follow, most error bars are suppressed. Mn 2ϩ quench experiments were analyzed by comparing the rate of decline of fluorescence, quantified as the slope of the regression line through the data points acquired during the last 2 min of the test period (after exchange of 0.5 mM Mn 2ϩ into the bath). The oxidation of DHE to ETH was quantified by calculating the average fluorescence during the final 2 min of measurement. ETH fluorescence was normalized for display by dividing the fluorescence of individual vessels by the mean of the controls. As described in a past study of NO generation (36) , that approach facilitates display without obscuring the variation or interfering with statistical analysis. The significance of differences between means was evaluated using Student's t-test (paired or unpaired, as appropriate) and ANOVA. For ANOVA, the StudentKewman-Keuls test was used to test significance. [Ca 2ϩ ] cyt signaling. We tested whether the nonselective PKC inhibitor STP affects ANG II-induced vasoconstriction and [Ca 2ϩ ] cyt signaling in DVR pericytes. ANG II (10 nM) constricted microperfused DVR from a mean internal diameter of 14.2 Ϯ 0.6 to 10.5 Ϯ 0.5 m (time ϭ 1 and 7 min, Fig. 1 ). When STP was included along with ANG II, constriction was eliminated; pre-and postexposure diameters were 13.9 Ϯ 0.3 and 13.4 Ϯ 0.4 m, respectively. In the presence of STP, the response to ANG II was statistically indistinguishable from that of DMSO-exposed time controls whose pre-and posttreatment internal diameters were 13.9 Ϯ 0.4 and 13.5 Ϯ 0.5 m, respectively.
RESULTS
Effect of PKC inhibition on ANG II vasconstriction and
To test whether blockade of [Ca 2ϩ ] cyt signaling might partially account for the inhibition of constriction by STP, we isolated pericytes from the underlying endothelia and examined their [Ca 2ϩ ] cyt responses. We (35) previously characterized pericytes isolated in this way and showed that they respond to ANG II with a classical peak and plateau [Ca 2ϩ ] cyt elevation. In contrast, the DVR endothelium responds to ANG Fig. 1 . Staurosporine (STP) inhibition of ANG II constriction. After the baseline internal diameter was recorded for 2 min, ANG II (10 Ϫ8 M) was added to the bath plus either the PKC inhibitor STP (10 Ϫ5 M, s, n ϭ 8) or its vehicle DMSO (F, n ϭ 9). These agents were removed from the bath after 5 min (time ϭ 7 min). A separate group of vessels was exposed to DMSO alone (E, n ϭ 6). ANG II-induced constriction of descending vasa recta (DVR) was completely blocked by PKC inhibition. *P Ͻ 0.05 vs. ANG II ϩ STP.
II with [Ca 2ϩ ] cyt reduction (29, 30, 34) . In this study, to verify that pericyte stripping properly separates these cells from the endothelium, we performed immunochemistry (Fig. 2) . Pericytes were labeled with antibody directed against smooth muscle actin and the endothelium was labeled with antibody targeted to isoform 2 of NHERF-2 (41). Stripped pericytes were positive for actin but not NHERF-2 (n ϭ 4).
Isolated, fura-2-loaded pericytes responded to ANG II, as expected, with a peak and plateau [Ca 2ϩ ] cyt response (Fig. 3) . PKC inhibition with STP diminished the peak and nearly eliminated the ensuing plateau. In Fig. 3 , the differences between ANG II and ANG II ϩ STP groups were significant (P Ͻ 0.05) for times Ͼ3.3 min. Baseline pericyte [Ca 2ϩ ] cyt was 50 to 100 nM, similar to that found in earlier studies (35, 52 (29, 34) . Mn 2ϩ was introduced into the bath to measure the rate of its entry into the pericytes as reflected by the rate of quench of fluorescence. Results are illustrated in Fig. 4A . Even before the addition of Mn 2ϩ , fura-2 fluorescence declined slowly. That decline is due to leak of fura-2 from the cytoplasm (35) . Five-minute preincubation with ANG II or STP had no effect on fura-2 leak.
After Mn 2ϩ (0.5 mM) was added to the bath, a very rapid reduction of fura-2 fluorescence occurred, related to Mn 2ϩ entry and fluorescence quenching. In the presence of STP, the quench rate was lower (Fig. 4, A and B) , verifying that PKC inhibition blocks permeation of Mn 2ϩ into ANG II-stimulated DVR pericytes. 5A ). Preliminary experiments showed DiOG to be very photosensitive, a property that might partially account for the slow rise in [Ca 2ϩ ] cyt . In view of this, to measure vasoconstriction, the room was darkened, and the preparation was briefly illuminated with the microscope light to record pre-and posttreatment images. After 15 min of exposure to DiOG (10 M, n ϭ 5), DVR constricted from a baseline diameter of 14.4 Ϯ 0.4 to 10.3 Ϯ 0.5 m (Fig. 5B , P Ͻ 0.05 vs. DMSO controls). For corroboration, we also tested the effect of PDBu, a less photosensitive agonist that activates PKC by a different mechanism. Like DiOG (Fig. 5A) , the pericyte [Ca 2ϩ ] cyt response to PDBu (Fig. 6A ) was characterized by a slow increase from an initial value of 51 Ϯ 32 nM toward a plateau of ϳ266 nM over an exposure time of 10 min (P Ͻ 0.05 vs. DMSO time controls for time Ͼ5.4 min, Fig. 6A ). PDBu constricted DVR on a similar time scale from an internal diameter of 13.8 Ϯ 0.4 to 11.3 Ϯ 0.8 m (P Ͻ 0.05 vs. DMSO time controls, Fig. 6B) .
Blockade (Fig. 7) . Within 2 min after the addition of diltiazem (10 M), [Ca 2ϩ ] cyt fell to 47 Ϯ 51 nM (P Ͻ 0.05 vs. vehicle controls, time ϭ 12-14 min, Fig. 7) .
The effect of diltiazem on PDBu stimulated Mn 2ϩ entry into the pericyte cytoplasm was also tested (Fig. 8) . Fura-2-loaded pericytes were exposed to PDBu (10 M) with or without diltiazem (10 M) for 5 min, following which Mn 2ϩ (0.5 mM) was added to the bath (Fig. 8A) . The rate of Mn 2ϩ quench was lower with diltazem (P Ͻ 0.05 vs. control, Fig. 8B ). These findings support a role for ANG II to activate Ca 2ϩ entry pathways via PKC phosphorylation of voltage-gated channels.
Activation of ROS generation. ROS can augment vasoconstriction by reacting with NO to produce peroxynitrite. They can also promote constriction through nonenzymatic genera- (0.5 mM) was added to the bath, quenching fura-2 in the cytoplasm. The ordinate shows fluorescence of fura-2 (F) divided by fura-2 fluorescence at time ϭ 0 (F0). Fluorescence of fura-2 was monitored at 510 nm during isosbestic excitation at 360 nm. B: means Ϯ SE of fluorescence quench rate in vehicle and STPtreated pericytes (n ϭ 9, each group, *P Ͻ 0.05). Values on the ordinate are the rate of decline of fluorescence, determined by linear regression, during the final 2 min of observation. tion of isoprostanes and sensitization of contractile proteins to [Ca 2ϩ ] cyt (9, 12, 39) . Using oxidation of DHE to ETH and other fluorescent products, we tested whether constriction of DVR by ANG II and PKC agonists leads to generation of ROS. We first determined whether ETH accumulation was greatest in DVR pericytes or endothelium. As shown in Fig. 9A , concomitant white light and confocal fluorescent images showed greater accumulation of fluorescence in pericytes. We then tested the ability of ANG II to enhance ROS generation. By itself, ANG II showed a tendency to increase oxidation of DHE, but this did not reach significance even after 40 min of observation. When ANG II AT 2 receptors were blocked with PD-123319, a robust increase in ETH was readily demonstrated (Fig. 9B) , suggesting a role for AT 2 activation to abrogate AT 1 receptor-mediated ROS generation. Statistical comparison of averaged fluorescence during the last 2 min is summarized in Fig. 9C . Identical conclusions are reached if one compares the rates of rise of fluorescence over the first 10 min rather than the total fluorescence achieved at the endpoints. The PKC agonist PDBu also enhanced ROS generation (Fig. 10A) . DPI is a flavoprotein inhibitor that blocks NADPH oxidase, and TEMPOL is a membrane-permeant SOD mimetic. The effects of those two antioxidants on PDBu stimulated ROS generation as shown in Fig. 10B . Both agents blocked the rate of oxidation of DHE.
DISCUSSION
The DVR pericyte is an important regulator of renal medullary perfusion. Studies (28, 30, 34 -36, 52) have shown that ANG II constricts DVR though mechanisms that involve pericyte plasma membrane depolarization, Ca 2ϩ -dependent Cl Ϫ channel activation, and Ca 2ϩ influx through a diltiazem-sensitive pathway. In this work, we continued studies of DVR contraction using ANG II as a benchmark agonist by testing the hypothesis that PKC activation plays an important role in its actions. The principal findings are that ANG II-induced vasoconstriction and pericyte [Ca 2ϩ ] cyt elevation are both blocked by PKC inhibition. Conversely, PKC activation induces constriction and [Ca 2ϩ ] cyt elevation. Finally, PKC activation by ANG II generates ROS via AT 1 receptor stimulation and AT 2 modulation. These data extend our knowledge of the cellular mechanisms by which ANG II constricts DVR pericytes and reinforce a role for ROS in renal medullary physiology (6, 8, 22, 26) .
STP prevented ANG II stimulated vasoconstriction (Fig. 1 ), pericyte [Ca 2ϩ ] cyt signaling (Fig. 3) , and Mn 2ϩ influx (Fig. 4 ). This favors a role for PKC activation to link receptor activation and pericyte [Ca 2ϩ ] cyt signaling. ANG II AT 1 receptors are a member of the seven membrane-spanning, G protein-coupled, superfamily that, through activation of phospholipase C, catalyze hydrolysis of phosphoinositide bisphosphate to yield inositol (1,4,5)-trisphosphate [Ins(1,4,5)P 3 ] and DAG (1, 13) . DAG activates both the Ca 2ϩ dependent, classical, and the Ca 2ϩ -independent, novel PKC isoforms (10, 25, 37) . PKC, in turn, is known to activate a variety of Ca 2ϩ entry pathways including the voltage-gated (L-type and T-type) Ca 2ϩ channels Ca v 1.x and Ca v 3.x, respectively (17, 25) , and to modulate activity of some isoforms of transient receptor potential cation channels (50) . In the DVR pericyte, PKC activation, whether resulting from ANG II AT 1 receptor activation or application of agonists (DiOG, PDBu), increases divalent cation entry and elevates pericyte [Ca 2ϩ ] cyt (Figs. 3, 5 , and 6). Differences were observed in the response of pericyte [Ca 2ϩ ] cyt to ANG II and PKC agonists. Unlike ANG II stimulation (Fig. 3) , DiOG and PDBu (Figs. 5 and 6) did not generate an early peak as part of their [Ca 2ϩ ] cyt response. This is largely as expected, because PKC activation does not gen- erate Ins(1, 4,5)P 3 , the signaling molecule needed to liberate Ca 2ϩ from cellular stores via the endoplasmic/sarcoplasmic reticulum Ins(1,4,5)P 3 receptor (1). In addition, the rise of [Ca 2ϩ ] cyt after DiOG and PDBu was characterized by a slow increase toward a plateau (Figs. 6 and 7) . In preliminary experiments, we observed that DiOG, in particular, is light sensitive to the point that strong microscope illumination could vasodilate vessels preconstricted with this agent. PDBu is less photosensitive and was therefore the PKC agonist of choice for subsequent experiments (Figs. 6 -8 and 10 ). The slow onset of DiOG and PDBu may also be related to their lipophilic nature and slow diffusion to cytoplasmic targets. Details of their pharmacology cannot be readily resolved in isolated perfused DVR and DVR pericytes, but consistency of the results obtained using PKC blockade (STP) and activation (DiOG, PDBu) points strongly toward the role of PKC in ANG II actions. PKC Fig. 8 . Effect of diltiazem on PDBu-stimulated Mn 2ϩ entry into ANG II-treated pericytes. A: protocol used to measure Mn 2ϩ entry into pericytes. After a 2-min baseline period, vessels were preexposed to PDBu (1 M) with or without diltiazem (10 M) for 5 min. Subsequently, Mn 2ϩ (0.5 mM) was added to the bath. The ordinate shows normalized fluorescence of fura-2 monitored at 510 nm during isosbestic excitation at 360 nm. B: means Ϯ SE of fluorescence quench rate in vehicle-exposed (n ϭ 8) and diltiazemtreated pericytes (n ϭ 7, each group, *P Ͻ 0.05). Values on the ordinate are the rate of decline of fluorescence, determined by linear regression, during the final 2 min of observation. Fig. 9 . Oxidation of dihydroethidium (DHE) to ethidium (ETH) by DVR pericytes. A: high-and low-power confocal images of DHE-loaded DVR (top and middle) are shown. A white light image is provided for comparison (bottom). ETH fluorescence is most prominent in pericyte cell bodies (*). B: with background subtracted, normalized ETH fluorescence is shown as a function of time in isolated DVR exposed to vehicle (n ϭ 9), ANG II (10 nM, n ϭ 8), or ANG II ϩ the AT2 receptor blocker PD-123319 (10 nM, n ϭ 9). ANG II tended to increase the rate of fluorescent labeling, but this did not achieve significance. Stimulation of AT1 receptors during concomitant AT2 receptor blockade led to a robust and significant increase in the rate of ETH labeling. C: summary of the ETH fluorescence from B shown as the mean of the final 2 min of data collection (*P Ͻ 0.05 vs. control). 49 ). We (52) previously demonstrated that diltiazem (10 M) lowers the plateau phase of the ANG II [Ca 2ϩ ] cyt response. In the present work, we confirmed that PKC inhibition also blocks the plateau response, (Fig. 3) . The similarity of the results is consistent with a role for PKC to activate diltiazem-sensitive channels in DVR pericytes. In support of this hypothesis, diltiazem-reduced PDBu stimulated Mn 2ϩ entry into the pericytes (Fig. 8) (15) recently demonstrated expression of Ca v 1.2␣ subunits in the juxtamedullary efferent circulation, including DVR. The specificity of some L-type channel blockers has been brought into question (7, 45) , and these results do not rule out the possibility that more than one pathway contributes to ANG II-stimulated Ca 2ϩ influx. Further delineation of pericyte Ca 2ϩ entry pathways will probably require electrophysiological study using voltage clamps above and below the threshold for activation of L-and T-type currents.
In addition to [Ca 2ϩ ] cyt , the contractile state of vascular smooth muscle is regulated through several intracellular signaling cascades that control the phosphorylation of myosin light chains (MLC). The balance of phosphorylation is determined by the activities of Ca 2ϩ /calmodulin-dependent MLC kinase (MLCK) and MLC phosphatase (31, 33) . The latter two enzymes are targets of signaling cascades that control sensitivity to [Ca 2ϩ ] cyt . Such sensitization can result in smooth muscle contraction even in the absence of overt [Ca 2ϩ ] cyt elevation (5, 37) . The ability of STP to nearly eliminate DVR vasoconstriction (Fig. 1) (53) . Many enzymes, including NO synthase, cyclooxygenases, lipoxygenases, epoxygenases, xanthine oxidase, and NADPH oxidase can generate ROS (9, 12, 39) . It is increasingly accepted, however, that the dominant source of ROS for bacterocidal activity in leukocytes and signaling in other cells is NADPH oxidase (14, 19, 44, 47) . This enzyme consists of cytosolic components (p47 phox , p67 phox ), a G protein (Rac1 or Rac2), and a membrane-associated cytochrome composed of two other subunits (p22 phox , gp91 phox ). The latter provide the final transfer of electrons from NADPH to O 2 in leukocytes. In nonphagocytic cells, including vascular smooth muscle, the gp91 phox subunit may be substituted by another isoform such as NOX1 or NOX4, and several NOX isoforms are expressed in individual cell types (4, 19, 20) . A role for elevation of [Ca 2ϩ ] cyt and PKC phosphorylation of p47 phox to activate NADPH oxidase is established, and PKC inhibitors reduce vascular production of ROS after stimulation with ANG II (13, 14, 40) and other agonists (23) . Activation of ANG II AT 1 receptors also enhances vascular smooth muscle production of O 2 Ϫ ⅐ through stimulation of phospholipase D, formation of phosphatidic acid, and activation of NADPH oxidases (14, 20, 48, 51) .
DVR are contractile vessels that supply blood flow to the renal medulla. The importance of ROS generation to the tonic maintenance of renal medullary blood flow has been well documented (6, 8, 54) . SOD inhibition and infusion of the SOD mimetic TEMPOL reduce and enhance medullary blood flow, respectively (54) , and chronic renal medullary SOD inhibition induces hypertension (22) . The thick ascending limb of Henle's loop has been identified as an important source of both O 2 Ϫ ⅐ and NO production (6, 8, 21, 26) . We confirmed that ANG II tends to increase ROS formation in DVR pericytes, but the effect did not achieve significance unless AT 2 receptors were concomitantly blocked with PD-123319 (Fig. 9C) . These results agree with the recent report of Mori and Cowley (24) showing that ANG II fails to increase ETH fluorescence in DVR pericytes during 250 s of measurement. The scale of the abscissa in Fig. 9C shows that a significant effect of ANG II on DHE oxidation could not be demonstrated, even with 10-fold longer observations. The trend, however, does favor ANG II enhancement of ROS production. As a consequence of intravessel variation and the requirement for across-group comparison, the DHE oxidation method is probably too insensitive to demonstrate ROS generation unless AT 2 blockade is employed to unmask AT 1 receptor-mediated effects.
Our prior finding (36) that TEMPOL abrogates ANG II constriction favors a role for it to stimulate significant O 2 Ϫ ⅐ production in the DVR wall. We (34) recently described the effect of AT 2 receptor blockade (PD-123319) and activation (CGP-42112A) on DVR endothelial Ca 2ϩ signaling and vasoconstriction. In that study, AT 2 blockade enhanced the ability of ANG II to inhibit the endothelial [Ca 2ϩ ] cyt response to vasodilators, but it did not affect the magnitude of the ANG II-stimulated pericyte [Ca 2ϩ ] cyt response. The effect of ANG II to inhibit endothelial [Ca 2ϩ ] cyt responses persisted after pericytes were removed from the vessel (35) . The ability of PD-123319 to enhance ROS formation in this study and the dominance of the ETH signal in pericytes (Fig. 9, A and C) suggests that the AT 2 receptors might exert their influences through actions in both endothelia and pericytes.
The ability of ANG II to inhibit DVR endothelial [Ca 2ϩ ] cyt signaling by vasodilators implies that the increase in tissue NO that buffers vasoconstrictor effects to preserve medullary blood flow (6) originate from sources other than DVR endothelia. Increasing attention has been focused on the possibility that signaling between the medullary thick ascending limb of Henle and outer medullary vascular bundles through diffusible paracrine agents might mediate local feedback to preserve oxygenation of the outer medullary interbundle region where vectoral NaCl transport occurs (6, 8, 29) . The effect of AT 2 stimulation to reduce ROS formation (Fig. 9 ) and facilitate endothelial [Ca 2ϩ ] cyt signaling (34) agrees with the general observation that AT 2 receptor actions favor intrarenal NO formation (2, 42) , because endothelial NO synthase is a Ca 2ϩ -dependent enzyme (11) and O 2 Ϫ ⅐ inactivates NO by reacting with it to form peroxynitrite (9) . The recent demonstration by Chabrashvili et al. (3) shows that AT 2 inhibition during chronic ANG II infusion increases urinary markers of oxidative stress and that NADPH oxidase subunit expression supports the role of AT 2 receptors in the abrogation of intrarenal ROS generation. Thus it is reasonable to postulate that physiological modulators of AT 2 activity or receptor expression might be an important link to the control of renal medullary perfusion and renal salt and water excretion.
